CONMED CORP (CNMD) Stock Balance Sheet
USA - NYSE:CNMD - US2074101013 - Common Stock
42.04 USD
-1.23 (-2.84%)
42.04 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 33.94M | 24.46M | 24.30M | 28.90M | 20.80M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 234.00M | 238.00M | 242.00M | 191.30M | 183.90M | |||
| Inventories | 362.00M | 347.00M | 318.00M | 332.30M | 231.60M | |||
| Other Current Assets | 27.00M | 31.00M | 31.00M | 28.60M | 23.80M | |||
| Total Current Assets | 658.00M | 640.00M | 616.00M | 581.20M | 460.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 117.00M | 156.00M | 137.00M | 133.30M | 128.30M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | 807.00M | 805.00M | 807.00M | 815.40M | 617.50M | |||
| Intangibles | 602.00M | 618.00M | 649.00M | 681.80M | 471.00M | |||
| Other Non-Current Assets | 145.00M | 77.00M | 80.00M | 85.80M | 89.00M | |||
| Total Non-Current Assets | 1.67B | 1.67B | 1.68B | 1.72B | 1.31B | |||
| TOTAL ASSETS | 2.33B | 2.31B | 2.30B | 2.30B | 1.77B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 710.00K | 720.00K | 710.00K | 69.70M | 12.20M | |||
| Accrued Expenses | 68.00M | 73.00M | 78.00M | 61.70M | 67.70M | |||
| Accounts Payable | 101.00M | 102.00M | 88.00M | 73.40M | 58.20M | |||
| Other Current Liabilities | 125.00M | 102.00M | 144.00M | 91.80M | 58.60M | |||
| Total Current Liabilities | 295.00M | 278.00M | 311.00M | 296.60M | 196.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 881.00M | 905.00M | 973.00M | 985.10M | 672.40M | |||
| Deferred Taxes/Income | 70.00M | 74.00M | 61.00M | 66.70M | 68.50M | |||
| Other Non-Current Liabilities | 80.00M | 86.00M | 121.00M | 203.70M | 43.00M | |||
| Total Non-Current Liabilities | 1.03B | 1.07B | 1.16B | 1.26B | 784.00M | |||
| TOTAL LIABILITIES | 1.33B | 1.34B | 1.47B | 1.55B | 980.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 575.00M | 560.00M | 453.00M | 412.60M | 496.60M | |||
| Additional Paid In Capital | 494.00M | 477.00M | 447.00M | 413.20M | 396.80M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 310.00K | 310.00K | 310.00K | 300.00K | 300.00K | |||
| Treasury Stock | -14.00M | -16.00M | -15.00M | -22.80M | -54.10M | |||
| Other Shareholders' Equity | -53.00M | -59.00M | -50.00M | -57.90M | -54.20M | |||
| Shares Outstanding | 31.00M | 31.00M | 31.00M | 30.50M | 29.40M | |||
| Tangible Book Value per Share | -13.0968 | -14.8387 | -20.0645 | -24.6459 | -10.3095 | |||
| Total Shareholders' Equity | 1.00B | 963.00M | 834.00M | 745.50M | 785.40M | |||
| TOTAL LIABILITIES AND EQUITY | 2.33B | 2.31B | 2.30B | 2.30B | 1.77B | |||
| Statistics | ||||||||
| Debt/Equity | 0.88 | 0.94 | 1.17 | 1.32 | 0.86 | |||
| Current Ratio | 2.23 | 2.30 | 1.98 | 1.96 | 2.34 | |||
| Return On Assets (ROA) | 4.73% | 5.72% | 2.78% | -3.51% | 3.54% | |||
| Return On Equity (ROE) | 10.97% | 13.71% | 7.67% | -10.81% | 7.96% | |||
| Return On Invested Capital (ROIC) | 7.55% | 8.30% | 4.94% | 2.82% | 5.66% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.68% | 8.40% | 5.00% | 2.87% | 5.73% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 26.02% | 29.00% | 19.30% | 11.90% | 19.29% | |||
All data in USD , ROIC based on taxRate of 0.19